273 publications
Sort by: Date / Relevance
Package advice esketamine nasal spray (Spravato®) for the treatment of adults with treatment-resistant major depressive disorder
Zorginstituut Nederland has completed its assessment whether esketamine nasal spray (Spravato®) can be included in the insured ...
Trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage
Zorginstituut Nederland has completed its assessment whether trastuzumab-emtansine (Kadcyla®) can be included in the insured ...
Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients
Zorginstituut Nederland has completed its assessment whether Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) can be ...
Indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) for the maintenance treatment for asthma in adults and adolescents of 12 years and older
Zorginstituut Nederland has completed its assessment whether indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) can ...
Osimertinib (Tagrisso®) for the treatment of locally advanced or metastatic non-small cell lung carcinoma (NSCLC) with an epidermal growth factor receptor (EGFR) mutation (reassessment)
The Minister of Medical Care has requested Zorginstituut Nederland to reassess whether osimertinib (Tagrisso®) for the treatment ...
Avelumab (Bavencio®) in combination with axitinib as a first-line treatment for adult patients with advanced renal cell carcinoma
Zorginstituut Nederland has completed its assessment whether avelumab (Bavencio®) in combination with axitinib can be included in ...
Conditional inclusion procedure for medicinal products
This document describes the conditional inclusion procedure for orphan drugs, conditionals and exceptionals.
Ibrutinib (Imbruvica®) for the treatment of Waldenstrom's disease
Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...
Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)
Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...
International strategic agenda 2020 National Health Care Institute
When performing its tasks, the National Health Care Institute (Zorginstituut Nederland, or ZIN) participates with various other ...